Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Pal-KCV peptide strengthens hair and reduces breakage by up to 52%.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Matriptase is crucial for skin, hair, and immune cell health, and its imbalance can lead to cancer.

TIP39 and PTH2R help control calcium levels and skin cell development.

Peptides show promise for diagnosing and treating pancreatic cancer with high precision and low side effects.

Human and mouse TGase3 enzymes are similar but differ near the activation site, crucial for their function in skin and hair development.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Tripeptides help heal wounds and regenerate skin by speeding up tissue repair and reducing inflammation.

TTD hair is brittle due to fewer sulfur amino acids and unstable disulfide bonds.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Targeted protein degradation could improve cancer treatment by effectively targeting the Wnt pathway.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

PRP injections are not effective for long-term treatment of temporal triangular alopecia.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

A new method creates precise, stable microscale structures with reduced friction and potential for complex designs.

A new genetic variant causes BRESHECK syndrome by disrupting cell growth and stress response.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

The GNP crosslinked scaffold with antibacterial coating is effective for rapid wound healing and infection prevention.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

TAK-279 effectively reduces psoriasis symptoms and is safe.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.